This company has been marked as potentially delisted and may not be actively trading. Jupiter Neurosciences (JUNS) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesTrendsBuy This Stock JUNS vs. GLSI, GNLX, BYSI, ANIX, NKTR, CTNM, BHST, HURA, THTX, and ATOSShould you be buying Jupiter Neurosciences stock or one of its competitors? The main competitors of Jupiter Neurosciences include Greenwich LifeSciences (GLSI), Genelux (GNLX), BeyondSpring (BYSI), Anixa Biosciences (ANIX), Nektar Therapeutics (NKTR), Contineum Therapeutics (CTNM), BioHarvest Sciences (BHST), TuHURA Biosciences (HURA), Theratechnologies (THTX), and Atossa Therapeutics (ATOS). These companies are all part of the "medical" sector. Jupiter Neurosciences vs. Its Competitors Greenwich LifeSciences Genelux BeyondSpring Anixa Biosciences Nektar Therapeutics Contineum Therapeutics BioHarvest Sciences TuHURA Biosciences Theratechnologies Atossa Therapeutics Greenwich LifeSciences (NASDAQ:GLSI) and Jupiter Neurosciences (NASDAQ:JUNS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk. Is GLSI or JUNS more profitable? Jupiter Neurosciences' return on equity of 0.00% beat Greenwich LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets Greenwich LifeSciencesN/A -450.87% -333.18% Jupiter Neurosciences N/A N/A N/A Does the media favor GLSI or JUNS? In the previous week, Jupiter Neurosciences' average media sentiment score of 0.94 beat Greenwich LifeSciences' score of 0.00 indicating that Jupiter Neurosciences is being referred to more favorably in the news media. Company Overall Sentiment Greenwich LifeSciences Neutral Jupiter Neurosciences Positive Does the MarketBeat Community favor GLSI or JUNS? Greenwich LifeSciences received 8 more outperform votes than Jupiter Neurosciences when rated by MarketBeat users. However, 100.00% of users gave Jupiter Neurosciences an outperform vote while only 47.37% of users gave Greenwich LifeSciences an outperform vote. CompanyUnderperformOutperformGreenwich LifeSciencesOutperform Votes947.37% Underperform Votes1052.63% Jupiter NeurosciencesOutperform Votes1100.00% Underperform VotesNo Votes Do analysts prefer GLSI or JUNS? Greenwich LifeSciences presently has a consensus price target of $39.00, suggesting a potential upside of 338.20%. Given Greenwich LifeSciences' higher possible upside, equities analysts plainly believe Greenwich LifeSciences is more favorable than Jupiter Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenwich LifeSciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Jupiter Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has better earnings and valuation, GLSI or JUNS? Jupiter Neurosciences has higher revenue and earnings than Greenwich LifeSciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreenwich LifeSciencesN/AN/A-$15.79M-$1.26-7.06Jupiter Neurosciences$230K178.45-$2.44MN/AN/A Do insiders and institutionals have more ownership in GLSI or JUNS? 4.2% of Greenwich LifeSciences shares are held by institutional investors. 51.7% of Greenwich LifeSciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryJupiter Neurosciences beats Greenwich LifeSciences on 8 of the 13 factors compared between the two stocks. Get Jupiter Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for JUNS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JUNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JUNS vs. The Competition Export to ExcelMetricJupiter NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.04M$415.98M$5.16B$8.52BDividend YieldN/A2.45%5.38%4.19%P/E RatioN/A7.2125.4919.14Price / Sales178.453.36412.59116.04Price / CashN/A8.4135.5255.99Price / Book9.540.897.975.74Net Income-$2.44M$10.55M$3.15B$248.81M Jupiter Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JUNSJupiter NeurosciencesN/A$1.24+32.4%N/AN/A$41.04M$230K0.005GLSIGreenwich LifeSciences1.9827 of 5 stars$9.20flat$39.00+323.9%-44.1%$122.99MN/A-11.503GNLXGenelux0.7077 of 5 stars$3.23+5.6%$17.75+449.5%+23.2%$121.88M$8K-3.4010High Trading VolumeBYSIBeyondSpringN/A$3.00+7.5%N/A+9.5%$120.95M$1.88M0.0080High Trading VolumeANIXAnixa Biosciences3.2252 of 5 stars$3.75+12.3%$9.00+140.0%+43.7%$120.79M$210K-9.625Negative NewsHigh Trading VolumeNKTRNektar Therapeutics4.3172 of 5 stars$9.25+7.7%$67.50+629.7%-49.6%$114.82M$87.25M-11.01220Positive NewsGap DownHigh Trading VolumeCTNMContineum Therapeutics2.176 of 5 stars$4.29-3.2%$22.50+424.5%-80.8%$114.61M$50M-2.1831News CoverageAnalyst ForecastBHSTBioHarvest SciencesN/A$6.84-5.0%$13.67+99.8%N/A$112.35M$27.70M-5.48N/APositive NewsHURATuHURA Biosciences1.426 of 5 stars$2.57+4.5%$12.67+392.9%N/A$112.26MN/A0.00N/AGap DownTHTXTheratechnologiesN/A$2.42-2.4%N/A+89.4%$111.27M$88.67M-24.20140Positive NewsATOSAtossa Therapeutics1.1532 of 5 stars$0.85+2.5%$6.17+624.6%-28.3%$109.94MN/A-3.878Gap Up Related Companies and Tools Related Companies GLSI Competitors GNLX Competitors BYSI Competitors ANIX Competitors NKTR Competitors CTNM Competitors BHST Competitors HURA Competitors THTX Competitors ATOS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JUNS) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersWhat a “Mar-a-Lago Accord” could mean for the US dollar.25-Year Market Vet Issues Urgent Dollar Warning He's spent 25 years tracking the flow of global money - now...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jupiter Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jupiter Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JUNS Stock Free JUNS Stock Alerts